tiprankstipranks
Boundless Bio Inc. (BOLD)
NASDAQ:BOLD
US Market
BOLD
Boundless Bio Inc.
RESEARCH TOOLSreports
Want to see BOLD full AI Analyst Report?

Boundless Bio Inc. (BOLD) Stock News & Sentiment

45 Followers
Boundless Bio Terminates Major Long-Term San Diego Lease
Premium
Company Announcements
Boundless Bio Terminates Major Long-Term San Diego Lease
1M ago
8K
BOLD
Boundless Bio Advances New Breast Cancer Drug BBI-940 Into First-in-Human Trial
Premium
Company Announcements
Boundless Bio Advances New Breast Cancer Drug BBI-940 Into First-in-Human Trial
3M ago
BOLD
Boundless Bio Terminates Early-Stage BBI-825 Cancer Trial: What Investors Should Know
Premium
Company Announcements
Boundless Bio Terminates Early-Stage BBI-825 Cancer Trial: What Investors Should Know
4M ago
BOLD
Boundless Bio Inc. Reports Q3 2025 Financial Results
Premium
Company Announcements
Boundless Bio Inc. Reports Q3 2025 Financial Results
7M ago
BOLD
Boundless Bio’s Innovative Cancer Study: A Potential Game-Changer?
Premium
Company Announcements
Boundless Bio’s Innovative Cancer Study: A Potential Game-Changer?
7M ago
BOLD
Innovative Cancer Treatment Approach and Promising Outlook Drive Buy Rating for Boundless Bio Inc.
Premium
Ratings
Innovative Cancer Treatment Approach and Promising Outlook Drive Buy Rating for Boundless Bio Inc.
7M ago
BOLD
Premium
Ratings
Hold Rating on Boundless Bio Inc.: Awaiting Clinical Validation of Innovative Therapies
9M ago
BOLD
More BOLD News >

BOLD News on the Web

Boundless Bio presents preclinical data for BBI-940 therapy at AACR
TipRanks News
Bullish
Boundless Bio Terminates Major Long-Term San Diego Lease
TipRanks News
Neutral
Boundless Bio Inc. (BOLD) Receives a Hold from Guggenheim
TipRanks News
Bearish
Boundless Bio reports Q4 EPS (58c), consensus (52c)
TipRanks News
Bullish
Boundless Bio sees cash runway into 2H28
TipRanks News
Neutral
Boundless Bio, Inc. (BOLD) Upgraded to Buy: Here's Why
Zacks
Bullish
Boundless Bio Advances New Breast Cancer Drug BBI-940 Into First-in-Human Trial
TipRanks News
Neutral
FMR LLC Reduces Stake in Boundless Bio Inc: A Strategic Portfolio Adjustment
GuruFocus News
Neutral

News Score - Last 7 Days

Neutral
BOLD
Sector Average
Media Buzz
This Week1 articles
Weekly Average0.25 articles
News Sentiment
This Week100%
Sector Average76%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BOLD’s Media Buzz Sentiment?
1 articles about BOLD were published this week. In an average week, 0.25 articles are published.
    What is BOLD’s weekly average amount of articles?
    In an average week, 0.25 articles about BOLD are published.
      What is BOLD’s News Sentiment?
      100% of articles about BOLD were positive this week, compared to its sector average of 76%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        CGENCompugen
        PROKProKidney
        ROIVRoivant Sciences
        Showing the stocks with the most bullish news sentiment over the past week